tiprankstipranks
Treace Medical cuts Fy23 revenue view to $182M-$186M from $191M-$197M
The Fly

Treace Medical cuts Fy23 revenue view to $182M-$186M from $191M-$197M

Consensus $194.3M. The Company “expects positive adjusted EBITDA in the fourth quarter of 2023 and continues to expect to show modest improvement in adjusted EBITDA for full-year 2023 compared to 2022.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on TMCI:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles